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In stepped‐wedge trials (SWTs), the intervention is rolled out in a random order
over more than 1 time‐period. SWTs are often analysed using mixed‐effects
models that require strong assumptions and may be inappropriate when the
number of clusters is small.
We propose a non‐parametric within‐period method to analyse SWTs. This
method estimates the intervention effect by comparing intervention and control
conditions in a given period using cluster‐level data corresponding to exposure.
The within‐period intervention effects are combined with an inverse‐variance‐
weighted average, and permutation tests are used. We present an example and,
using simulated data, compared the method to (1) a parametric cluster‐level
within‐period method, (2) the most commonly used mixed‐effects model, and
(3) a more flexible mixed‐effects model. We simulated scenarios where period
effects were common to all clusters, and when they varied according to a distri-
bution informed by routinely collected health data.
The non‐parametric within‐period method provided unbiased intervention
effect estimates with correct confidence‐interval coverage for all scenarios.
The parametric within‐period method produced confidence intervals with
low coverage for most scenarios. The mixed‐effects models' confidence inter-
vals had low coverage when period effects varied between clusters but had
greater power than the non‐parametric within‐period method when period
effects were common to all clusters.
The non‐parametric within‐period method is a robust method for analysing
SWT. Themethod could be used by trial statisticians whowant to emphasise that
the SWT is a randomised trial, in the common position of being uncertain about
whether data will meet the assumptions necessary for mixed‐effect models.
KEYWORDS
cluster randomised trial, confidence interval coverage, permutation test, simulation study, stepped
wedge trial
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1 | BACKGROUND
Parallel cluster‐randomised trials (CRTs) with sufficient numbers of clusters can be analysed in 2 ways: at the cluster
level using cluster‐level summaries of observation‐level data, or by accounting for correlation in the observation‐level
data using statistical models. Cluster‐level methods are robust and allow simple computation of risk differences and risk
ratios, which are easier to interpret than odds ratios unless outcomes are rare.1,2 By contrast, observation‐level models
with binary outcomes are less robust to small numbers of clusters.3
Stepped‐wedge trials (SWTs) randomise clusters to sequences.4 Each sequence introduces the intervention at
different times, so that clusters allocated to each sequence are in the control condition for a unique length of time before
switching to the intervention condition for the remainder of the study. The times between when the clusters in 1
sequence switch and clusters in the next sequence switch are referred to as “periods”. Outcome data are typically
collected for all periods 5 and sometimes also before the clusters in the first sequence starts receiving the intervention,
and after the last sequence starts to receive the intervention. Outcomes are assigned to the period in which the individual
was exposed. These may occur within the period but may occur during a later period 5 or even after the rollout is
complete.6
The intervention effect can be estimated from 2 “directions” of comparison: within periods or between periods.
Within‐period comparisons are akin to a parallel CRT because each cluster is in 1 condition only, determined at ran-
dom. For each period, observations corresponding to exposure to the control condition are compared with observations
corresponding to exposure to the intervention condition. These are often known as “vertical” comparisons.
Between‐period comparisons compare observations corresponding to control and intervention conditions within each
cluster across periods. Between‐period comparisons are confounded with changes in participation and in the outcome
over time (secular trends or “period effects”) because each cluster is in the intervention condition later than the control
condition.5 Analyses that incorporate between‐period comparisons must adjust for period effects and must also make
assumptions about the correlation of observations within each cluster. These are also known as horizontal comparisons.
SWTs are most commonly analysed using mixed‐effect models that combine within‐period and between‐period com-
parisons.7 These have been shown to be sensitive to misspecification of the random effects 8-10: they can produce biased
estimates and underestimate standard errors. The correlation structure of the data is usually not known in advance of a
trial. To ensure a valid analysis is pre‐specified, it may be safer to plan an analysis that does not require these assumptions.
Permutation tests are 1 way to account for correlations without specifying the correlation structure within clusters; Ji
et al9 and Wang and DeGruttola 10 suggest using a mixed‐effect model for effect estimation and permutation tests for
calculating confidence intervals (CIs) and P‐values. Although they find this method to be more robust than a mixed‐
effect model alone, this requires that the mixed‐effect model provides an unbiased estimate of the treatment effect
and this is not always the case.8
An alternative approach to estimating an intervention effect is to combine within‐period comparisons.7 Published
literature has suggested combining within‐period comparisons using inverse variance weights.4,11,12 We hypothesise that
such a method will be a more robust way to estimate an intervention effect because this does not require assumptions
about, or estimation of, a correlation structure. Formulae for estimating a parametric variance for this combined esti-
mate are also given in this literature. These either require assuming a correlation structure,11 or estimating this structure
from the data 4,12; these can be problematic if the assumed structure is incorrect, or if there are insufficient clusters per
sequence to estimate the correlations.
In this paper, we introduce a cluster‐level, within‐period, analysis method that uses permutation tests. We contrast
this against a parametric cluster‐level within‐period approach,12,13 the most commonly used mixed‐effects model,14
and a more flexible mixed‐effects model. As illustration, we applied the methods to data from a SWT assessing the effect
of a new tuberculosis (TB) diagnostic test on patient outcomes. Using simulations based on routinely collected data, we
assessed the performance of the methods in terms of bias, coverage, and power.
2 | ANALYSIS METHODS
We compared 4 methods for analysing SWTs. Two use only the within‐period comparisons and analyse at the cluster‐
level (referred to as within‐period methods), and 2 are mixed‐effect models that incorporate the between‐period compar-
isons and analyse at the observation‐level (referred to as mixed‐effect models). We focused on a binary outcome, which is
common in SWTs.7
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2.1 | Within‐period methods
Because within‐period comparisons are not possible during periods where all clusters are in 1 condition, these methods
only use data collected after clusters allocated to the sequence with the earliest introduction of the intervention switch to
the intervention and before clusters allocated to the sequence with the latest introduction of the intervention switch to
the intervention. In contrast to currently published within‐period analyses,11 these methods do not make assumptions
about the correlation of observations between periods.
2.1.1 | Non‐parametric within‐period method
For this method, we use a within‐period cluster‐level analysis, with permutation tests to calculate CIs and P‐values.
The method uses the following 3 stages (see R code in Supporting Information A):
1. First, we calculate a summary of the outcome, Yij, in each cluster i corresponding to exposure to the control or inter-
vention conditions during period j; for binary outcomes, these could be log odds (to calculate odds ratios), log risks
(to calculate risk ratios), or risks (to calculate risk differences). Other summary measures can be used for different
outcome types.
2. Next, we calculate the period‐specific intervention effect, bθj, as the difference between the mean cluster‐period
summaries for the intervention and the control conditions during period j:
bθj ¼ 1c1j ∑i:Xij¼1Yij − 1c0j ∑i:Xij¼0Yij
where c1j and c0j are the numbers of clusters in the intervention condition and the control condition, respectively,
during period j, and Xij is an indicator denoting whether cluster i was allocated to receive the intervention or control
condition during period j, equal to 1 for intervention and 0 for control.
3. Last, we combine the period‐specific intervention effect estimates using an inverse‐variance weighted average, to
give an overall estimated intervention effect bθ: bθ ¼ ∑j¼ J
j¼1
wj
w
bθj
where w ¼ ∑j¼ Jj¼1wj, using weights based on the pooled variance of the period‐specific estimated intervention effect
allowing for the unequal number of clusters in each condition. These weights are calculated as:
wj ¼ dVar bθj −1 ¼ c0j−1 s20j þ c1j−1 s21jc0j þ c1j−2
 !
1
c0j
þ 1
c1j
 " #−1
where s20j and s
2
1j are the empirical variances of the cluster‐period summaries in the control and intervention
conditions, respectively, for each period j.
We use a permutation test to calculate P‐values and CIs, which requires no assumptions about the correlation
between the effects in each period. We randomly permute the assignment of clusters to sequences and therefore the time
at which clusters switch from control to intervention conditions. We calculate an intervention effect for each permuta-
tion, as described previously. The P‐value for the null hypothesis of no intervention effect is given by the proportion of
permutations with an estimated intervention effect the same as or more extreme than that observed. We use 1000
permutations to allow us to calculate P‐values to 3 decimal places.
Permutation tests can be used to generate 95% CIs using an iterative process. The following process is conducted
iteratively for several given intervention effect values to find the values that return a 1‐sided P‐value of 0.025: the upper
and lower confidence limits.
First, we test for evidence against a given intervention effect θA by subtracting it from the observed cluster‐period
summaries in the intervention condition:
Yij
* ¼ Yij−θA if i:Xij ¼ 1
Yij if i:Xij ¼ 0:
(
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Then, using the new intervention‐condition cluster‐period summaries and the original control‐condition cluster‐
period summaries, Y *ij, we estimate an intervention effect as described earlier and permute the assignment of clusters
to sequences to generate the P‐value.
The method assumes that the clusters are independent of one another within each period and assumes exchangeabil-
ity of observations within clusters within each period. No assumptions are made about correlations between observations
or cluster summaries over different periods, and no assumptions are made about the period effects. We assume that the
intervention effect is the same for all clusters in all periods.
Outcomes of different types can be analysed, and several different intervention effects can be estimated. In this paper,
we focus on calculating odds ratios to make comparisons with logistic mixed‐effect models. This means we calculate log
odds of the cluster summaries:
Yij ¼ log
pij
1−pij
 !
where pij is the proportion of individuals in cluster i during period j with the outcome of interest. The log odds is not
defined for clusters with a proportion of 1 or 0. To include these clusters, we used a heuristic adjustment, adding 0.5
to both the number of individuals with the outcome of interest and the number of individuals without the outcome,
in the affected clusters only.15 We will also demonstrate calculation of a risk difference in the example; the risk difference
does not require the heuristic adjustments.
2.1.2 | Parametric within‐period method
Several papers have described a method of combining period‐specific intervention effects in the context of longitudinal
data.12,13,16 This method could also be used for the analysis of SWTs. We applied this method using a cluster‐level anal-
ysis for comparability with the non‐parametric within‐period method. The method uses the following 4 stages:
1. Cluster‐period summaries are calculated as in the non‐parametric within‐period method, earlier, with the use of
heuristic adjustments when necessary.
2. Generalised estimating equations, assuming a normal distribution of the cluster summaries, robust standard errors,
and an independent working correlation matrix on data from across the trial periods are used to calculate period‐
specific intervention effects, using the following model:
Yij ¼ μj þ θjXij þ ϵij
where Yij are summaries of the outcome in each cluster‐period, μj is the mean of the cluster‐period summaries in
period j, θj is the intervention effect in period j, and ϵij are the residuals.
3. The resulting period‐specific intervention effects, bθj, are combined as
bθ ¼ ∑j¼ J
j¼1
wj bθj
where w ¼ w1;…;wJ½  ¼ 1;…; 1½ bΛ−1w 1;…; 1½  −1bΛ−1w 1;…; 1½ , and bΛw is the covariance matrix for the period‐specific
parameters bθj estimated by the generalised estimating equations.
4. The resulting intervention effect estimate follows a normal distribution with variance bwbΛbw and so confidence inter-
vals and P‐values can be constructed parametrically.
As with the non‐parametric within‐period method, we focus on estimation of an odds ratio, Yij = log (pij/(1 − pij)),
but other intervention effects can be calculated, and other outcome types can be analysed in a similar way.
2.2 | Mixed‐effects models
We used 2 mixed‐effect models that have been suggested for SWT analysis. We used the normal distribution for the
calculation of CIs.
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2.2.1 | Cluster mixed‐effect model
The first model was described by Hussey and Hughes.17 This model has been shown to produce CIs that are too
narrow when misspecified8-10 and so is now thought to be unsuitable for general use in the analysis of SWTs. It
is included here because it is commonly used in practice. It has been adapted to a logistic model for a binary
outcome as:
logit P Y ijk ¼ 1
   ¼ μþ βj þ θXij þ ui
where Yijk is the outcome in individual k at time j in cluster i, μ is the log‐odds of the outcome in the first period in
the control condition, βj is the change in the outcome from the first period to period j, θ is the overall intervention
effect, and ui∼N 0; σ2u
 
is a random effect for cluster i.
This model assumes that clusters are independent of one another; that the intervention effect and period effects are
common to all clusters; and that observations are equally correlated within clusters across all periods.
2.2.2 | Cluster‐period mixed‐effect model
A more flexible mixed‐effects model has been recommended for use with SWTs 18-20:
logit P Y ijk ¼ 1
   ¼ μþ βj þ θXij þ ui þ qij:
where ui∼N 0; σ2u
 
is a random effect for each cluster, and qij∼N 0; σ2q
 
is a random effect for each cluster‐period.
Using this model, observations in the same cluster and same period are more correlated than observations in the same
cluster but different periods. However, the correlation of observations in different periods is the same for each pair of
periods, and the total variance is fixed to be the same in all periods.
There is a growing literature on designing SWTs that use this model,18,19 but there is currently no assessment of its
use in trial analysis.
3 | APPLICATION TO TB DIAGNOSTIC TRIAL
We applied the 4 methods described previously to a SWT conducted in Brazil that assessed the effect of a new TB
diagnostic test on outcomes of adults started on TB treatment.21
3.1 | Description of the study
The new diagnostic test (Xpert MTB/RIF) is more sensitive than the standard smear microscopy method and provides a
result for rifampicin drug resistance.22 Clusters were 14 laboratories used to diagnose TB in 2 cities in Brazil. Patients
who were diagnosed with TB in these laboratories during an 8‐month period were enrolled, and their treatment outcome
followed up for between 15 and 23 months after diagnosis. Unfavourable patient outcomes were defined as death, lost‐to‐
follow‐up during treatment, transfer out of clinic (including to more specialist centres for those not responding to treat-
ment), or suspected drug resistance. In the first month, all the laboratories were in the control condition using sputum
smear microscopy. At the start of each subsequence month, pairs of laboratories started using the new diagnostic tech-
nology in a random order. In the final month, all laboratories were using the new diagnostic test. Unlike the published
analysis of this trial, we do not include data from the first and final months, where all laboratories were in the control
condition, or where they were all in the intervention condition, respectively. We estimated, using the cluster mixed‐effect
model within each period, that patients' outcomes had an intra‐cluster correlation coefficient (ICC) of 0.003 throughout
the trial.
3.2 | Results
In the published report of the TB diagnostic trial,21 the authors found no evidence that the new diagnostic test
reduced unfavourable outcomes among 3926 TB patients. They used a mixed‐effects model with a fixed effect
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for the intervention, and a random effect for cluster (crude OR = 0.92 95% CI 0.79, 1.06; a similar result was
found in analysis adjusting for sex, age, city, HIV status, and diagnosis status). Neither analysis adjusted for period
effects. We found a similar result when we repeated this analysis on our subset of 3009 TB patients that excludes
data from the period where all laboratories were in the control or all were in the intervention condition (results
not shown).
All methods gave similar estimates of the odds ratio (see upper panel of Table 1), but the strength of evidence
against no effect differed: from P = 0.02 (both within‐period methods) to P = 0.10 (both mixed‐effect models). We
used the non‐parametric and parametric within‐period methods to estimate the risk difference (see lower panel of
Table 1), which gave similar estimates of effect (risk differences of −4.8% and − 4.2%, respectively); however, the
evidence against no effect was different, with P = 0.04 for the non‐parametric method and P = 0.007 for the
parametric method.
Table 2 shows the 3 stages for calculating the risk difference using the non‐parametric within‐period method. The
risk difference for the intervention effect ranged from +1.7% to −10.0% across the 6 periods, and the overall estimated
risk difference, combining estimates across the 6 periods with inverse variance weights, was −4.8%; that is a 4.8%
reduction in the risk of an unfavourable outcome using the new diagnostic test. Permutation tests gave a 95% CI of
(−10.0%, −0.3%) with some evidence of an effect (P = 0.04).
TABLE 1 The impact of introducing a new TB diagnostic test to laboratories on unfavourable outcomes among TB patients, using different
analysis methods. Mixed‐effects models used observation‐level data; within‐period methods used cluster‐level data
Analysis Method Intervention Effect P‐Value
Odds ratio
Non‐parametric within‐period method 0.78 (0.61, 0.96) 0.02
Parametric within‐period method 0.85 (0.74, 0.98) 0.02
Cluster mixed‐effect model 0.83 (0.67, 1.03) 0.10
Cluster‐period mixed effect model 0.83 (0.67, 1.03) 0.10
Risk difference
Non‐parametric within‐period method −4.8% (−10.0%, −0.3%) 0.04
Parametric within‐period method −4.2% (−7.2%, −1.1%) 0.007
TABLE 2 The estimated risk difference and its components, for each step using the non‐parametric within‐cluster method. The mean and
variance of cluster level risks were calculated for each condition in each period, which were then used to calculate the risk difference and its
variance in each period, which were summarised with an inverse‐variance weighted average
Stage
Period
1 2 3 4 5 6
(1) Control (smear microscopy) arm:
Number of clusters 12 10 8 6 4 2
Mean of cluster‐level risks 30.5% 26.5% 33.9% 32.4% 40.7% 38.4%
Intervention (Xpert MTB/RIF) arm:
Number of clusters 2 4 6 8 10 12
Mean of cluster‐level risks 32.2% 23.8% 23.9% 30.2% 33.3% 34.6%
(2) Risk difference +1.7% −2.7% −10.0% −2.2% −7.4% −3.7%
(3) Control arm:
Variance of cluster‐level risks
0.009 0.005 0.006 0.005 0.012 0.036
Intervention arm:
Variance of cluster‐level risks
0.040 0.015 0.001 0.002 0.007 0.020
Relative weight (wj/ wj) 0.05 0.13 0.27 0.41 0.11 0.03
Weighted average of risk differences −4.8%
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4 | SIMULATION STUDY
We performed a simulation study to investigate the performance of our 4 methods in scenarios with different period
effects and ICCs, and for several SWT designs.
4.1 | Data
We used local‐authority‐level data on uptake of National Health Service health checks in England in 2013 to 2014 to
inform the simulation study. Health checks were offered to all adults aged 40 to 74 every 5 years by GPs and third parties
to assess risk of diabetes, heart disease, kidney disease, stroke, and dementia.23 Details of how we generated the scenarios
to be used in the simulation study from these data are given in Supporting Information B. The mean of the local author-
ity‐level percentage of patients accepting health checks when offered was 49% in the first quarter of 2013; this increased
to 54% in the last quarter. At the start of 2014, the mean was 46%; this increased to 56% in the last quarter. We used these
health check data to generate 4 scenarios (Figure 1).
We generated period effects that were common to all clusters, and period effects that varied between clusters to the
degree that was observed in the data. We expected the within‐period methods to be unbiased and have correct coverage
in both the common and the varying period effects scenarios.
We assessed the power of the methods using 2 scenarios with different values of ICC. For one, we used the between‐
cluster variability observed in the data (ICC ≈ 0.08 in the first quarter of 2013, hereafter referred to as “high ICC”), and
for another we used one fifth of the observed between‐cluster variability (ICC ≈ 0.02 in the first quarter of 2013, hereafter
referred to as “low ICC”).
When the period effects varied between the clusters, the between‐cluster variance changed over time. Therefore, the
ICC changed over time. Over the 2 years, the ICC varied between 0.06 and 0.19 for the high ICC and varying period
effects scenario, as observed in the data, and between 0.01 and 0.04 for the low ICC and varying period effects scenario.
4.2 | Trial designs
In each of the 4 scenarios (common and varying period effect and high and low ICC), we simulated SWTs of an inter-
vention designed to increase acceptance of health checks when offered by a GP. The intervention effect had an odds ratio
of 1.3 (log‐odds ratio = 0.26), favouring the intervention.
We applied 4 trial designs to each of the 4 scenarios to assess how the numbers of sequences, the number of clusters
per sequence, and the total number of clusters affected the performance of the methods. The 4 trial designs had either 3
or 11 sequences with either 3 or 11 clusters per sequence (Figure 2). This resulted in trial designs with a total of 9 clusters
(3 sequences with 3 clusters per sequence), 33 clusters (3 sequences with 11 clusters per sequence, or 11 sequences with 3
FIGURE 1 Simulated log‐odds for 33 clusters over 2 years with no intervention in the 4 scenarios; common period effects with a high ICC
(0.08), common period effects with a low ICC (0.02), varying period effects with a high ICC (0.08), and varying period effects with a low ICC
(0.02)
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clusters per sequence), or 121 clusters (11 sequences with 11 clusters per sequence). Unlike the mixed‐effect models, the
within‐period methods require clusters in both the control and intervention condition in each period, and therefore we
simulated designs that started when clusters in the first sequence switched to the intervention and stopped when clusters
in the final sequences switched to the intervention (Figure 2).
The total number of observations for each cluster across the trial was selected from a log‐normal distribution (μ=5.3,
σ2=0.25) regardless of the trial design; this gave a median total cluster size of 200 (interquartile range 143‐281) with
observations evenly distributed across the periods. This gave a median total sample size of 1800 for designs with 9 clus-
ters, 6600 for designs with 33 clusters, and 24 200 for designs with 121 clusters. In scenarios with common period effects,
the smallest trial (9 clusters) had 35% power to detect an odds ratio of 1.3 with the cluster mixed‐effects model, and the
largest trial (121 clusters) had >99.9% power.24
Each of the 4 trial designs for each of the 4 scenarios was simulated 1000 times, allowing us to estimate coverage of
95% CIs to within 1.4%.
4.3 | Evaluation of methods
We analysed each simulated trial using both within‐period methods and both the mixed‐effects models. We compared
the 4 methods in terms of bias, coverage, and power for each trial design and scenario, in line with recommendations
from Burton et al.25
We calculated the proportion of within‐period analyses that required the heuristic adjustment and the proportion of
mixed‐effects analyses that converged. Bias was calculated as the deviation of the mean of the estimates from the true
log‐odds ratio. Effect estimates within half a standard deviation of the true effect were considered unbiased.25 We com-
pared the variability of the estimates given by each method using the ratio of the variances. The coverage of the 95% CIs
was calculated as the proportion of simulations with P > 0.05 against the true effect, ie, the proportion of CIs that
contained the true effect. We calculated the power to detect an effect at 5% significance as the proportion of simulations
with P < 0.05 against no intervention effect.
4.4 | Simulation study results
For all simulations, the within‐period methods provided effect estimates and P‐values, all of the cluster mixed‐effect
models converged, and all but 2 of the cluster‐period mixed‐effects models converged. For the cluster‐level analyses,
the heuristic adjustment was used in 84% to 100% of simulations with a trial design of 11 clusters per sequence and
FIGURE 2 Diagrams of the 3 and 11 sequence designs. For each, we simulated trials with 3 or 11 clusters per sequence
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11 sequences (mean of 2‐7 times per simulation), 10% to 64% with 3 clusters per sequence and 11 sequences (mean of 0‐1
times per simulation), once with 11 clusters per sequence and 3 sequences, and was not used with 3 clusters per sequence
and 3 sequences. See Supporting Information C for more details.
4.4.1 | Bias and variability
Figure 3 shows the mean and half a standard deviation either side of the mean of the estimated intervention effects for
each analysis method, scenario, and trial design. All analysis methods gave unbiased intervention effects in all scenarios
and trial designs (see Supporting Information D).
The mixed‐effect models' estimates had similar variability, and the within‐period methods' estimates also had similar
variability. The within‐period methods' estimates were between 1.56 and 6.18 times more variable than the mixed‐effects
models' estimates when period effects were common to all clusters. When period effects differed between clusters, the
variability of the estimates was more alike between analyses: the within‐period methods' estimates were between 0.88
and 2.23 times as variable as the mixed‐effect models' estimates. This difference between the common‐period‐effect
scenarios and varying‐period‐effect scenarios was largely driven by an increase in variability of mixed‐effects models'
estimates. In all scenarios, the difference in variability was greater when there were more sequences because of a reduc-
tion in variability in the mixed‐effect models estimates, and when the ICC was high because of an increase in variability
in the within‐period methods' estimates.
FIGURE 3 Graph of mean and ½ standard deviation either side of the estimated log‐odds ratios for each method, scenario, and trial design.
The vertical grey line denotes the true log‐odds ratio. The mean estimates are shown with the circles. The horizontal lines depict ½ standard
deviation either side of the mean. The effects are organised first by whether the period effects vary between cluster, then by the ICC, and
finally by the trial design (number of sequences x the number of clusters allocated to each sequence) [Colour figure can be viewed at
wileyonlinelibrary.com]
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4.4.2 | Coverage
Figure 4 shows the coverage of the 95% CIs for each method, scenario, and trial design (see Supporting Information E for
further details).
The non‐parametric within‐period method performed well; it achieved 94% to 96% coverage for both common and
varying period effects, both levels of ICC, and all trial designs.
The parametric within‐period method performed badly; it had poor 95% CI coverage in all scenarios considered,
particularly for designs with 3 clusters per sequence. For the mixed‐effects models, both gave reasonable coverage
(92%‐96%) when period effects were common to all clusters (shown in the left half of Figure 4), although they may
have 95% CIs with low coverage in scenarios with 9 clusters and low ICC (92% coverage). However, when period
effects varied between clusters (shown in the right half of Figure 4), both produced under‐coverage of 95% CIs.
The degree of under‐coverage was severe for the cluster mixed‐effect model, particularly when the ICC was high
(60%‐77% coverage and 87%‐93% coverage for high and low ICC, respectively). For designs containing 33 or more
clusters, the cluster‐period mixed‐effect model achieved nominal coverage with a low ICC (93%‐95%) but gave low
coverage with a high ICC (90%‐93%). For designs with fewer than 33 clusters, the cluster‐period model produced
under‐coverage of the 95% CI (85%‐90%).
4.4.3 | Power
Table 3 shows the power for each method, scenario, and trial design (see Supporting Information F for further details).
The power of the non‐parametric within‐period method ranged from 10% to 100%. Power was higher with more clus-
ters and lower ICC. For example, with common period effects, 11 sequences, and 3 clusters per sequence, the method
had 32% and 78% power for high and low ICC, respectively. Whether period effects were common or varying had limited
impact on the power.
FIGURE 4 Coverage of 95% confidence intervals for each analysis, scenario, and trial design. Coverage between 96.4% and 94.6% is
nominal. The coverage estimates are organised first by whether the time‐trends vary between cluster, then by the ICC, and finally by the
trial design (number of sequences x number of cluster allocated to each sequence) [Colour figure can be viewed at wileyonlinelibrary.com]
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The power of the parametric within‐period method will not be discussed because of its poor 95% CI coverage for all
scenarios.
When period effects were common, the non‐parametric within‐period method had lower power than both mixed‐
effects models. The difference ranged from 0% to 61% less power; power loss was greatest when ICC was high and with
11 sequences. The 2 mixed‐effect models had similar power.
When period effects were varying, the under‐coverage of the CIs described above means that the power for the
mixed‐effects models will be overestimated. However, for the sake of making some comparisons, we consider the clus-
ter‐period model, because it had closer to nominal coverage than the cluster mixed‐effects model. The difference in
power between the cluster‐period model and the non‐parametric within‐period when the period effects were common
ranged from 2% to 41.8% difference; when the period effects were varying, the differences ranged from 0% to 37.3%.
The larger of those differences were when the ICC was high, which was also when the cluster‐period model had lowest
coverage and therefore power would be artificially inflated.
5 | DISCUSSION
We have presented a novel non‐parametric within‐period method to analyse SWTs and compared this with a parametric
within‐period analysis method, a commonly used mixed‐effects model, and a more flexible mixed‐effects model. Of the 4
methods considered, the non‐parametric within‐period method was the only approach to consistently provide correct CI
coverage, although all of the methods gave unbiased point estimates. The lack of nominal coverage from the other
methods in some or all of the scenarios considered made most comparisons of the power of the methods invalid. Where
comparisons were reliable and the simulated data mimicked the real data correlation structure, the difference in power
between the mixed‐effect models and the non‐parametric within‐period power was smaller than expected.
Most literature on the analysis of SWTs focuses on the use of mixed‐effect models.14 We assessed the cluster mixed‐
effect model, and the cluster‐period mixed‐effect model because they are widely used in practice 7 and in methodological
literature 18,19 respectively. However, we found that neither of these models gave nominal coverage when our simulated
data reflected the correlation structure seen in real data. Whilst this has been previously shown for the cluster mixed‐
effect model,8-10 it is novel for the cluster‐period mixed‐effect model.
This is the first study to show that the magnitude of under‐coverage of CIs from the cluster mixed‐effects model when
period effects vary between clusters is dependent on the ICC. This builds on previous research that noted this low cov-
erage.8-10 Our simulation study also suggests that the mixed‐effect model may produce CIs with low coverage when used
with only 9 clusters, similar to Barker et al.26 Use of a t‐distribution rather than the normal distribution could overcome
TABLE 3 Power for each method, scenario, and trial design
Period
Effects ICC Sequences
Clusters per
Sequence
Power
Non‐parametric
within‐period method
Parametric
within‐period method
Cluster
model
Cluster‐period
model
Common 0.02 3 3 26.9 51.7 48.7 47.1
0.02 3 11 72.8 77.4 91.8 90.1
0.02 11 3 78.1 93.9 96.4 96.4
0.02 11 11 99.8 100 100 100
0.08 3 3 11.3 32.9 35.5 33.9
0.08 3 11 29.6 35.4 73.1 70.5
0.08 11 3 32.3 74.1 93.4 93.4
0.08 11 11 79.5 95.4 100 100
Varying 0.02 3 3 22.4 48.7 45.0 39.9
0.02 3 11 79.5 85.3 89.0 85.2
0.02 11 3 79.9 93.0 95.4 94.5
0.02 11 11 100 100 100 100
0.08 3 3 10.5 32.4 45.3 22.1
0.08 3 11 27.9 35.5 63.2 36.3
0.08 11 3 35.7 73.0 80.4 67.9
0.08 11 11 87.0 98.0 99.8 99.2
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this small sample issue.27 By contrast, the non‐parametric within‐period method gave correct coverage in all scenarios,
including with as few as 9 clusters. This extends the work of Ji et al 9 and Wang and DeGrutolla 10 who also investigated
the use of permutation tests for SWT analysis.
The parametric within‐period approach is not to be recommended for SWT analysis. It had low CI coverage in all
scenarios and trial designs. The low CI coverage explains the small P‐value this method gave in our example. For this
method, the number of parameters estimated is large relative to the number of clusters. For example, in the scenario
with 11 sequences, the covariance matrix consists of 10 variance parameters and 45 covariance parameters for each pair
of periods, 10 within‐period log odds‐ratios, and 10 control log odds, estimated with data from only 33 or 121 clusters.
The non‐parametric within‐period method had lower power than the mixed‐effects models when period effects were
common to all clusters (ie, when the mixed‐effects model assumptions were true). In this scenario, the non‐parametric
within‐period method had much higher variability in the estimated intervention effects, particularly when the ICC was
high. This is consistent with previous findings.4,11 However, when the period effect varied between clusters, the differ-
ence between the power of the non‐parametric within‐period method and the cluster‐period mixed‐effect model was
reduced. This is despite the power of the cluster‐period mixed‐effect model being over‐estimated because of CI under‐
coverage. This demonstrates that in realistic scenarios, the reduction in power from using a within‐period analysis is less
than suggested by previous literature.4,11 The main challenge is anticipating the correlation structure of the data when
planning an analysis. Choosing a method that is robust irrespective of the correlation structure avoids pre‐specifying
an analysis that is inappropriate.
We have found that the power of the non‐parametric within‐period method is dependent on the total number of clus-
ters, and not on the number of sequences. This contradicts the design effects reported in Hayes and Moulton 2 where the
power of a within‐period analysis decreased as the number of sequences increased. Hayes and Moulton explain that the
loss of power is due to the increasing imbalance in the number of clusters in each condition within the periods. However,
their calculations did not account for clustering or correlations between periods. In our analysis, the permutation tests
account for all correlations in the data, and our findings suggest that this minimises the loss of power due to the imbal-
ance in the number of clusters—perhaps even reversing it. Further research is needed on how the number of sequences
affects the power of this methods in a wider range of scenarios. Consistent with previous research,17,28 the statistical
power of the mixed‐effects model was dependent on the number of sequences, as well as the number of clusters.
The within‐period methods required a heuristic correction for when the prevalence of the outcome in a cluster dur-
ing a period was either 0 or 1 because of their use of a cluster‐level analysis. The heuristic was frequently required for
trial designs with 11 sequences because each cluster‐period contained fewer observations in this design. Previous
research has noted that this, and the use of cluster summaries to estimate an odds ratio, has led to a biased intervention
effect estimate.29 In our simulation study, the intervention effect estimates calculated using cluster‐level methods were
consistently slightly larger than the estimates from the mixed‐effect models, but they were within our pre‐specified
boundary of 1/2 a standard deviation from the true effect, and the difference was not of practical relevance. The heuristic
is not required for calculating risk difference or other difference estimates, such as mean differences or rate differences,
but it would be required for ratio estimates.
Other analysis methods may exist or be developed that are able to provide robust estimates whilst including the
between‐period comparisons. Research is needed into generalized estimating equations or the addition of robust stan-
dard errors in the context of SWTs. However, these methods still rely on having many clusters.30
A strength of the simulation study is that we used National Health Service health check uptake data at the local‐
authority level to demonstrate the effect of realistic variability in period effects, leading to a realistic correlation structure.
We explored the performance of the methods in a range of realistic settings by varying the ICC and looking at several
different trial designs.
The simulation study has limitations. For our results to be most applicable to health research, we explored binary
outcomes and so calculated odds ratios. Further research is required to examine whether the mixed‐effects models are
more robust to misspecification with a continuous outcome, and to explore the properties of the non‐parametric
within‐period method with continuous and rate outcomes. Other features of SWTs, such as delayed intervention,
sparse data collection, or lags were not considered. The performance of the non‐parametric within‐period method
requires further research in the presence of more extreme ICCs. A limitation of using cluster‐level analyses is that
power is lost when there is high variability in cluster sizes. Whilst we allowed cluster size to vary, we did not explore
the effect of different levels of variability on power. When there is high variability in cluster size, the method could be
extended to weight clusters in the analysis within each period by their size, as described by Hayes and Moulton,2 to
improve precision.
12 THOMPSON ET AL.
The weights used in the non‐parametric within‐period method were chosen to minimise the number of assumptions.
The permutation test was chosen as this makes no assumptions about the composition of the data other than that of
exchangeability and testing a strong null hypothesis (so assumes a common intervention effect).31 There may be
improvements in power available from making assumptions about the data. However, adding assumptions may negate
the benefits of the non‐parametric within‐period method, and Matthews and Forbes suggest that the gains will be small.4
Our inverse variance weights assumed the same variance in the intervention and control condition, but efficiency may be
improved by relaxing this assumption in settings where the variance was expected to be different in each condition. The
method could be extended to incorporate adjustment for baseline individual‐level covariates, as described by Hayes and
Moulton.2
Presenting absolute as well as relative effect sizes can improve interpretation, as is recommended by the CONSORT
statement.32 We have shown that the non‐parametric within‐period method can be simply adapted to provide estimates
of risk differences. The method could also be extended to calculate risk ratios. Model‐based methods of calculating risk
difference and risk ratios are available,29,33 but further research is needed into their use in SWTs.
The non‐parametric within‐period approach to the analysis of SWTs, using permutation tests, is an unbiased and
robust alternative to the commonly used mixed‐effects modelling approach. Researchers designing and analysing SWTs,
in the common position of being uncertain about whether data will meet the assumptions necessary for mixed‐effect
models, should consider this as an alternative method to emphasise that the SWT is a randomised trial.
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